BIOCEPT INC (BIOC) Stock Analyst Earnings Estimates
NASDAQ:BIOC - Nasdaq - US09072V6002 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.46M 396.56% | 61.249M 123.05% | 25.858M -57.78% | 2.526M -90.23% | 6.601M 161.32% | 21.906M 231.86% | |
| EBITDA YoY % growth | -14.38M 35.02% | -879K 93.89% | -30.328M -3,350.28% | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.47M 32.91% | -2.409M 84.43% | -31.983M -1,227.65% | -24.438M 23.59% | -23.525M 3.74% | -17.27M 26.59% | |
| Operating Margin | -56.34% | -3.93% | -123.69% | -967.47% | -356.39% | -78.84% | |
| EPS YoY % growth | -1.89 99.36% | -0.10 94.71% | -43.07 -42,970.00% | -5.66 86.86% | -1.41 75.14% | -0.87 38.41% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -2.78 71.87% | -0.47 98.57% |
| Revenue Q2Q % growth | 613.02K -39.12% | 625.26K -97.58% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -5.408M 46.76% | -5.553M 82.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -32.70 -18,066.67% | -7.50 | -25.20 | -336.17% |
| Q3 2022 Q2Q % growth | -9.90 -33,100.00% | -5.97 | -3.93 | -65.91% |
| Q2 2022 Q2Q % growth | -0.31 -121.43% | -0.16 | -0.15 | -89.95% |
| Q1 2022 Q2Q % growth | -0.16 -184.21% | -0.14 | -0.02 | -12.04% |
| Q4 2021 Q2Q % growth | -0.18 -228.57% | -0.19 | 0.01 | 7.12% |
| Q3 2021 Q2Q % growth | 0.03 106.98% | 0.07 | -0.04 | -54.75% |
| Q2 2021 Q2Q % growth | -0.14 72.00% | -0.16 | 0.02 | 14.22% |
| Q1 2021 Q2Q % growth | 0.19 117.27% | % | ||
| Q4 2020 Q2Q % growth | 0.14 107.00% | -0.28 | 0.42 | 150.84% |
| Q3 2020 Q2Q % growth | -0.43 82.80% | -0.48 | 0.05 | 10.30% |
| Q2 2020 Q2Q % growth | -0.50 86.84% | -0.51 | 0.01 | 1.96% |
| Q4 2019 Q2Q % growth | -2.00 | -1.02 | -0.98 | -96.08% |
| Q3 2019 Q2Q % growth | -2.50 | -2.75 | 0.25 | 9.22% |
| Q2 2019 Q2Q % growth | -3.80 | -1.94 | -1.86 | -96.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 589K -94.45% | % | ||
| Q1 2023 Q2Q % growth | 673K -96.63% | % | ||
| Q4 2022 Q2Q % growth | 25.858M 85.02% | 3.331M | 22.527M | 676.28% |
| Q3 2022 Q2Q % growth | 1.007M -94.24% | 9.721M | -8.714M | -89.64% |
| Q2 2022 Q2Q % growth | 10.611M -11.92% | 12.723M | -2.112M | -16.60% |
| Q1 2022 Q2Q % growth | 19.945M 12.30% | 11.72M | 8.225M | 70.18% |
| Q4 2021 Q2Q % growth | 13.976M -24.49% | 11.33M | 2.646M | 23.36% |
| Q3 2021 Q2Q % growth | 17.47M 165.09% | 16.392M | 1.078M | 6.57% |
| Q2 2021 Q2Q % growth | 12.047M 1,209.48% | 9.935M | 2.112M | 21.26% |
| Q1 2021 Q2Q % growth | 17.76M 1,124.83% | % | ||
| Q4 2020 Q2Q % growth | 18.51M 939.89% | 12.568M | 5.942M | 47.28% |
| Q3 2020 Q2Q % growth | 6.59M 330.72% | 2.556M | 4.034M | 157.82% |
| Q2 2020 Q2Q % growth | 920K -22.69% | 1.326M | -406K | -30.62% |
| Q1 2020 Q2Q % growth | 1.45M 42.16% | 1.944M | -494K | -25.41% |
| Q4 2019 Q2Q % growth | 1.78M | 1.733M | 47K | 2.71% |
| Q3 2019 Q2Q % growth | 1.53M | 1.479M | 51K | 3.45% |
| Q2 2019 Q2Q % growth | 1.19M | 1.325M | -135K | -10.19% |
| Q1 2019 Q2Q % growth | 1.02M | 1.461M | -441K | -30.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | 83.63% |
| Revenue | 0% | N/A | 0% | -63.99% |